Literature DB >> 8444516

Chemical and biological characterization of iron-protein succinylate (ITF 282).

P Cremonesi1, I Caramazza.   

Abstract

ITF 282 is an iron succinyl casein complex containing 5% iron. The main property of the derivative is to keep iron bonded at acidic pH values. This accounts for a better tolerability of the compound compared with iron salts, during the treatment of iron deficiency. Pharmacological studies in normal and anemic rats demonstrated that this iron complex is almost as active as ferrous sulphate against iron deficiency anemia, but it is significantly less potent in increasing serum iron. Better gastrointestinal tolerability of ITF 282 was demonstrated in rats and dogs. Chemical and pharmacological properties of iron-protein succinylate are described.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8444516

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  3 in total

1.  Overview of clinical trials in the treatment of iron deficiency with iron-acetyl-aspartylated casein.

Authors:  Flavio Lazzari; Maria Carrara
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

2.  Spray-Dried Whey Protein Concentrate-Iron Complex: Preparation and Physicochemical Characterization.

Authors:  Indrajeet Singh Banjare; Kamal Gandhi; Khushbu Sao; Rajan Sharma
Journal:  Food Technol Biotechnol       Date:  2019-09       Impact factor: 3.918

3.  Iron Protein Succinylate in the Management of Iron Deficiency Anemia: A Comparative Study with Ferrous Sulphate at Low and High Therapeutic Doses.

Authors:  Katia Urso; Javier Leal Martínez-Bujanda; Jaime Moscoso Del Prado
Journal:  Nutrients       Date:  2021-03-17       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.